drugset / Trial / NCT02450682
Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study
RandomizedParallel-groupOpen-label
Summary
This study is being done to determine if apixaban is more safe, when compared to warfarin, at reducing the risk of bleeding during CIED procedures.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-01
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apixaban | Small molecule | — | — |
| Subject | Warfarin | Small molecule | — | — |